<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對照品 > 對照品 > 工作對照品 >
    Tafenoquine-d3 Succinate
    產(chǎn)品基本信息
    產(chǎn)品編號:T004762
    產(chǎn)品名稱:Tafenoquine-d3 Succinate
    產(chǎn)品CAS:
    規(guī)格含量:25mg
    產(chǎn)品價格:面議
    聯(lián)系我們:
    產(chǎn)品詳細介紹
    標(biāo)準(zhǔn)品編號: T004762
    名稱: Tafenoquine-d3 Succinate
    別名: N4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl]-1,4-pentanediamine-d3;Tafenoquine-d3; WR 238605-d3;
    參考CAS號: 106635-81-8 - unlabelled
    分子式: C??H??D?F?N?O?
    分子量: 584.6
    類別: Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: Tafenoquine-d3 Succinate is the labelled analog of Tatenoquine (T004760), a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the prevention and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase.
    參考文獻


    2011-2018 信陽萊耀生物科技有限公司 @ 信陽埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      四虎自拍偷拍 | 香蕉网在线视频 | 天天综合天天添夜夜添狠狠添 | 久久久久久麻豆 | 婷婷五月天色 |